Where does Eureka Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Eureka Therapeutics, Inc. ranks #7,139 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Eureka Therapeutics, Inc. hold?

Eureka Therapeutics, Inc. holds 46 US utility patents granted between 2015 and 2024, spanning 5 technology areas.

What is Eureka Therapeutics, Inc.'s Innovation Score?

Eureka Therapeutics, Inc. has an Innovation Score of 42.0 out of 100 (top 32% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Eureka Therapeutics, Inc. focus on?

Eureka Therapeutics, Inc.'s top technology area is C07K (Peptides) with 45 patents, ranking #207 of 3,615 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Is Eureka Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Eureka Therapeutics, Inc.'s recent grant velocity is +311% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Eureka Therapeutics, Inc.'s patents?

Eureka Therapeutics, Inc.'s patents average 28.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Eureka Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Eureka Therapeutics, Inc.

USPTO PatentsView assignee record - 46 granted patents across 5 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Eureka ranks #7,139 of 49,997 tracked US assignees by granted-patent volume, with 46 patents across 5 technology areas.

#7,139
of 49,997 US assignees by volume: Top 32%
by Innovation Score (42.0/100): 28.6
avg claims per patent: +311%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7139 · US Corporation #7,139 · 46 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 46 grants
UPPER-Q #7,139/49,997
PHOTO-FINISH Danfoss Power…
CPC-NARROW C07K · 5 areas
INNOV-PAR 42.0/100
CLAIMS-DENSE 28.6 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +311% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Danfoss Power Solutions Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Eureka’s 42.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.3 pts (32%) Velocity 5.8 pts (14%) Breadth 7.9 pts (19%) Claim depth 15.0 pts (36%)

Qualcomm Incorporated · highest

85
Diebold Self-Service… · near

42
Eureka Therapeutics · this assignee

42
J A Woollam · near

42
Qingdao Haier · near

42
SII Printek · near

42
3D Lighting… · lowest

7

What this shows Eureka's Innovation Score is 42.0/100 (top 32% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Eureka?

Each dot is one of Eureka’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Eureka’s own 28.6 claims/patent is ABOVE the 14.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Eureka vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Eureka's grants concentrate

Eureka Therapeutics, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 97.8% of grants classified under C07K (Peptides). Peak complete grant year is 2021 (11 grants) versus a trough of 1 in 2015. By volume, Eureka sits between Danfoss Power Solutions Inc. and GE Jenbacher GmbH Co OG.

Eureka's three-year grant acceleration

From 2019–2021 to 2022–2024, Eureka Therapeutics, Inc. moved from 22 to 19 grants (0.86x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Danfoss Power Sol…

46
Digicert

46
Durr Systems

46
Eisenmann

46
Five Prime Therap…

46
Foro Energy

46
Gamesa Innovation…

46
GE Jenbacher OG

46
Eureka Therapeuti… ◀

46

What this shows Eureka holds 46 patents at rank #7,139, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Eureka

By rank, the assignees closest to #7,139 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Eureka's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Eureka, neither rank-band nor same-CPC leaders (those blocks stay above). In C07K (Peptides), Eureka ranks #207 of 3,615 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (42 here).

J.A. Woollam Co., Inc. 42 Diebold Self-Service Systems, Division of Diebold, Incorporated 42 SII Printek Inc. 42 Qingdao Haier Co., Ltd. 42

Eureka's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 32% higher than 68% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Eureka Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	2.2%
2017	1	2.2%
2018	3	6.5%
2019	4	8.7%
2020	7	15.2%
2021	11	23.9%
2022	6	13.0%
2023	6	13.0%
2024	7	15.2%

Which technologies does Eureka Therapeutics, Inc. patent most?

C07K - Peptides 45

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 45

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 42

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 19

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 19

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Eureka Therapeutics, Inc.'s patent record in context - here's where to go next.

Eureka Therapeutics, Inc.'s lead technology class is C07K (Peptides), 97.8% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #7,139 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Eureka Therapeutics, Inc. against Danfoss Power Solutions Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.